Tissue Tranglutaminase (Ttg) Test Market: By Type (Serological, Biopsy, and others), and By End Users (Hospitals & Clinics, Homecare, Research Organisations, others) - Global Forecast Till 2027Market HighlightsThe tissue transglutaminase (tTG) testing is used for the diagnosis of certain autoimmune diseases, which is mostly restricted to celiac disease.
According to Celiac Disease Foundation in 2016, hospitalization have increased by 600% from 1998 to 2013.Increasing prevalence of autoimmune diseases mainly celiac disease, increasing geriatric global pool, and increasing investments healthcare drives the market growth.
likely to affect the market growth negatively.Global tTG testing MarketSome of key players profiled in the report are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.
Additionally, concentration of major research companies and research organizations in the developed countries of this region boost the market growth.Europe is the second largest market in the world due to high income and healthcare penetration.Asia Pacific region is expected to grow rapidly.
China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market.
Introduction2.1 Definition2.2 Scope Of The Study2.2.1 Research Objective2.2.2 Assumptions2.2.3 Limitations2.3 Market Structure2.4.